A Phase III, Randomized, Two-armed, Triple Blinded, Parallel, Active Controlled Non-Inferiority Clinical Trial of Stivant (AryoGen Trastuzumab) Efficacy and Safety in Comparison to Avastin in Metastatic Colorectal Cancer
Latest Information Update: 25 Jan 2021
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors AryoGen Pharmed
- 22 Apr 2020 Results published in the Clinical Therapeutics
- 05 Feb 2019 Status changed from active, no longer recruiting to completed.
- 19 Sep 2017 Status changed from recruiting to active, no longer recruiting.